Ministry of Health, Labour and Welfare (MHLW), with the Pharmaceuticals and Medical Devices Agency (PMDA) doing the scientific review and safety monitoring
Is Ipamorelin legal in Japan?
Not approved as a medicine here.
Ipamorelin has no approval in PMDA's approved-drug lists, and PMDA's package-insert database returns no ipamorelin product. Under the PMD Act a drug needs MHLW approval (Art. 14) before it is marketed, selling one marketed without approval is prohibited (Art. 55(2)) and advertising it is banned (Art. 68). Individuals may import a prescription drug for their own use up to one month's supply and may not pass it on, and physicians may import an unapproved drug for a patient under their own responsibility. The WADA Prohibited List 2026 names ipamorelin under S2 (growth hormone secretagogues).
Last verified 2026-09-29 · how we verify
Ipamorelin elsewhere
Sources (7)
- 01Approved new drugs list (Japanese), fiscal 2026 to date, covering approvals from May to September 2026 (承認品目一覧(新医薬品))Pharmaceuticals and Medical Devices Agency (PMDA) · 2026-09 · accessed 2026-09-29
- 02List of Approved Drugs, April 2004 to February 2026 (new drugs)Pharmaceuticals and Medical Devices Agency (PMDA) · 2026 · accessed 2026-09-29
- 03Prescription drug package insert and review report search (医療用医薬品 添付文書等情報検索)Pharmaceuticals and Medical Devices Agency (PMDA) · 2026-09-29 · accessed 2026-09-29
- 04Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (PMD Act), consolidated textDigital Agency (e-Gov Law Search) · 2026-05-21 · accessed 2026-09-29
- 05Personal import of pharmaceuticals and related products (医薬品等の個人輸入について)Ministry of Health, Labour and Welfare (MHLW) · 2025 · accessed 2026-09-29
- 06World Anti-Doping Code International Standard: Prohibited List 2026World Anti-Doping Agency (WADA) · 2025-09 · accessed 2026-09-29
- 07Japan Anti-Doping Agency (JADA) websiteJapan Anti-Doping Agency (JADA) · 2026 · accessed 2026-09-29